WHO recommendations : Uterotonics for the prevention of postpartum haemorrhage

WHO recommendations Uterotonics for the prevention of postpartum haemorrhage

The primary goal of this guideline is to provide a foundation for the implementation of interventions shown to have been effective in reducing the burden of PPH (postpartum haemorrhage). Health professionals responsible for developing national and local health policies constitute the main target aud...

Descripción completa

Detalles Bibliográficos
Autor principal: World Health Organization (author)
Autor Corporativo: World Health Organization, author, issuing body (author)
Formato: Libro electrónico
Idioma:Inglés
Publicado: Geneva : World Health Organization 2018.
Materias:
Postnatal care.
Ver en Biblioteca Universitat Ramon Llull:https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009816687406719
Tabla de Contenidos:
  • Acknowledgements
  • Acronyms and abbreviations
  • Executive summary
  • 1. Introduction
  • 1.1. Background
  • 1.2. Aim
  • 1.3. Target audience
  • 1.4. Scope of the recommendations
  • 2. Methods
  • 2.1. Executive Guideline Steering Group (2017-2019)
  • 2.2. WHO Steering Group
  • 2.3. Guideline Development Group (GDG)
  • 2.4. Evidence Synthesis Group (ESG)
  • 2.5. Observers
  • 2.6. External Review Group (ERG)
  • 2.7. Identification of priority questions and outcomes
  • 2.8. Evidence identification and retrieval
  • 2.9. Quality assessment and grading of the evidence
  • 2.10. Formulation of recommendations
  • 2.11. Decision-making during the GDG meetings
  • 2.12. Management of declarations of interests
  • 2.13. Document preparation and peer review
  • 3. Recommendations and supporting evidence
  • 3.1. Guiding principles
  • 3.2. Recommendations
  • 4. Dissemination and implementation of the recommendations
  • 4.1. Dissemination and evaluation
  • 4.2. Implementation considerations
  • 5. Research implications
  • 6. Applicability issues
  • 6.1. Anticipated impact on the organization of care and resources
  • 6.2. Monitoring and evaluating guideline implementation
  • 7. Updating the recommendations
  • 8. References
  • Annex 1. External experts and WHO staff involved in the preparation of the recommendations
  • Annex 2. Priority outcomes used in decision-making
  • Annex 3. Summary and management of declared interests from GDG members
  • Web annex 1. Oxytocin versus placebo or no treatment: Evidence to Decision framework
  • Web annex 2. Carbetocin versus placebo or no treatment: Evidence to Decision framework
  • Web annex 3. Misoprostol versus placebo or no treatment: Evidence to Decision framework
  • Web annex 4. Ergometrine/methylergometrine versus placebo or no treatment
  • Web annex 5. Oxytocin and ergometrine versus placebo or no treatment: Evidence to Decision framework
  • Web annex 6. Injectable prostaglandins versus placebo or no treatment: Evidence to Decision Framework
  • Web annex 7. Choice of uterotonic agents: Evidence to Decision framework.

Ejemplares similares